EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a clinical algorithm for monitoring and prognostic assessment in patients with CKD after COVID-19

Tatiana RAZLOG, Eugeniu RUSSU, Liliana GROPPA

One Health & Risk Management · 30.07.2026 · 7 (3) · 4-11

DOI: 10.38045/ohrm.2026.3.01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift One Health & Risk Management, online erschienen am 30.07.2026. Verfasst von Tatiana RAZLOG und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic kidney disease and coronavirus disease 2019 represent a high-risk intersection, yet renal follow-up after coronavirus disease 2019 remains insufficiently standardized. We developed and internally validated a risk-stratified clinical algorithm for monitoring and prognostic assessment of patients with chronic kidney disease after coronavirus disease 2019. Materials and Methods. This was a prospective cohort study of 280 non-dialysis patients with chronic kidney disease stages G2-G5: 140 post-coronavirus disease 2019 and 140 controls. At 6 to 12 months, we assessed estimated glomerular filtration rate, proteinuria, and inflammatory, metabolic, and hematologic markers. Coronavirus disease 2019 severity and the occurrence of acute kidney injury during infection were recorded. Predictors of advanced chronic kidney disease stages G4-G5 were identified by multivariate logistic regression; algorithm performance was evaluated by calibration and receiver operating characteristic analysis.

Results

The decline in renal function was comparable between groups. In post-coronavirus disease 2019 patients, persistent proteinuria, elevated serum phosphate, and low hemoglobin independently predicted advanced chronic kidney disease (odds ratio 5.0, 1.8, 1.4, respectively (p

Zitieren

APA

RAZLOG, T., RUSSU, E., & GROPPA, L. (2026). Development of a clinical algorithm for monitoring and prognostic assessment in patients with CKD after COVID-19. One Health & Risk Management, 7(3), 4-11. https://doi.org/10.38045/ohrm.2026.3.01

Vancouver

RAZLOG T, RUSSU E, GROPPA L. Development of a clinical algorithm for monitoring and prognostic assessment in patients with CKD after COVID-19. One Health & Risk Management. 2026;7(3):4-11. doi:10.38045/ohrm.2026.3.01

BibTeX
@article{RAZLOG2026,
  author = {RAZLOG, Tatiana and RUSSU, Eugeniu and GROPPA, Liliana},
  title = {Development of a clinical algorithm for monitoring and prognostic assessment in patients with CKD after COVID-19},
  journal = {One Health & Risk Management},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {4--11},
  doi = {10.38045/ohrm.2026.3.01}
}
Kostenlos starten →